Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Clinician's RoundtableEvaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Melanoma Treatment Breakthroughs: Improving Long-Term Survival
Medical Industry FeatureMelanoma Treatment Breakthroughs: Improving Long-Term Survival
Personalized Care in Atopic Dermatitis: Addressing Patient-Specific Factors
Clinician's RoundtablePersonalized Care in Atopic Dermatitis: Addressing Patient-Specific Factors
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Clinician's RoundtableAI and Hair Loss: Measuring Progress with Data-Driven Insights
Challenges in AI-Driven Dermatology: Understanding Current Limitations
Clinician's RoundtableChallenges in AI-Driven Dermatology: Understanding Current Limitations
Navigating Nail Psoriasis: Treatment Strategies for Patient-Centered Care
Clinician's RoundtableNavigating Nail Psoriasis: Treatment Strategies for Patient-Centered Care
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CEFinally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
CME/CECurrent Experiences in Identifying and Treating Itch in Patients on Hemodialysis
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
CME/CEUnveiling the Latest Advancements in CKD-Associated Pruritus Care
Navigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
Medical Industry FeatureNavigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
Best Practices for an Aesthetic Neurotoxin Approach
Medical Industry FeatureBest Practices for an Aesthetic Neurotoxin Approach
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Medical Industry FeatureTreating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Expert Perspectives on a Treatment for Plaque Psoriasis
Medical Industry FeatureExpert Perspectives on a Treatment for Plaque Psoriasis
- 03/25/2025
- 03/24/2025
- 03/24/2025
- 03/21/2025
- 03/19/2025